Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer.
about
Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Multicenter analysis of neoadj ...... n HER2-positive breast cancer.
@en
Multicenter analysis of neoadj ...... n HER2-positive breast cancer.
@nl
type
label
Multicenter analysis of neoadj ...... n HER2-positive breast cancer.
@en
Multicenter analysis of neoadj ...... n HER2-positive breast cancer.
@nl
prefLabel
Multicenter analysis of neoadj ...... n HER2-positive breast cancer.
@en
Multicenter analysis of neoadj ...... n HER2-positive breast cancer.
@nl
P2093
P2860
P50
P1476
Multicenter analysis of neoadj ...... n HER2-positive breast cancer.
@en
P2093
Coralia Bueno
Fernando Moreno
Gabriela Torres
Maria Del Monte-Millan
Miguel Martín
Miguel Sotelo
Miriam Lobo
Mónica Granja
Paloma Peinado
Yolanda Jerez
P2860
P2888
P304
P356
10.1007/S10549-016-4098-Z
P407
P577
2016-12-31T00:00:00Z